DrugRehab.com provides information regarding illicit and prescription drug
addiction, the various populations at risk for the disease, current statistics and trends, and
psychological disorders that often accompany addiction. You will also find information on spotting
the signs and symptoms of substance use and hotlines for immediate assistance.
Treatment for addiction takes many forms and depends on the needs of the individual.
In accordance with the American Society of Addiction Medicine, we offer information on
outcome-oriented treatment that adheres to an established continuum of care. In this section, you
will find information and resources related to evidence-based treatment models, counseling and
therapy and payment and insurance options.
Treatment for addiction takes many forms and depends on the needs of the
individual. In accordance with the American Society of Addiction Medicine, we offer
information on outcome-oriented treatment that adheres to an established continuum of
care. In this section, you will find information and resources related to evidence-based
treatment models, counseling and therapy and payment and insurance options.
The recovery process doesn't end after 90 days of treatment. The transition back to
life outside of rehab is fraught with the potential for relapse. Aftercare resources such as
12-step groups, sober living homes and support for family and friends promote a life rich with
rewarding relationships and meaning.
Our community offers unique perspectives on lifelong recovery and substance use
prevention, empowering others through stories of strength and courage. From people in active
recovery to advocates who have lost loved ones to the devastating disease of addiction, our
community understands the struggle and provides guidance born of personal experience.
A new report from the U.S. Senate claims the Comprehensive Addiction and Recovery Act of 2016 (CARA) is ineffective because of a lack of funding. CARA was supposed to expand addiction prevention efforts, bolster training programs and increase access to addiction treatment.
However, an October report by the Democratic Staff of the Senate Committee on Finance claimed “the bill was ‘comprehensive’ in name only; without funding, its policies are little more than empty promises.”
Senate Committee on Finance Chair Ron Wyden, D-Ore., released the report on October 10, nearly two weeks after Congress adjourned.
“I’m extremely disheartened that Congress has closed up shop yet again without acting on its core promise to provide essential funding for proven opioid addiction treatment and prevention efforts,” Wyden said in a press release.
On Sept. 29, Congress passed a continuing resolution to keep the government running until Dec. 9. The resolution added about $7.1 million in funding for CARA, well short of the $920 million Democrat Senators requested before the bill was passed.
Republicans have argued that the federal government is already providing more funding for opioids than it ever has and that there would be more opportunities to add funding in the future.
The House and Senate negotiated the provisions of CARA for the first half of 2016 before President Barack Obama signed the final version into law on July 22. Senate Democrats proposed multiple amendments to provide emergency funding for the bill, but the efforts were blocked by Republicans.
When Obama signed CARA, he said he was disappointed that the law did not include “any real resources.” The president requested $1.1 billion to fight addiction, but the law only authorized $181 million in funding.
The lack of funding means people seeking treatment may have to face long waiting lists or travel long distances to find a center with an open bed.
Long Waiting Lists, Lack of Resources Deter Recovery
The Senate’s report was titled “Dying Waiting for Treatment: The Opioid Use Disorder Treatment Gap and the Need for Funding.” It cited several studies that indicate services are unavailable to the majority of people seeking addiction treatment.
A 2015 study published in Annals of Family Medicine found that 30 million people lived in counties without access to Suboxone (buprenorphine-naloxone), a medication for opioid use disorders. The authors concluded that increased access to buprenorphine-naloxone treatment in rural America could abate the rising numbers of overdoses.
In a 2015 article in the American Journal of Public Health, public health experts found that 75 percent of opioid treatment programs in 38 states were operating at 80 percent capacity or higher. They concluded that “significant gaps between treatment need and capacity exist at the state and national levels.”
A third study published in the Journal of the American Medical Association reported that less than one-sixth of people with opioid use disorders accessed treatment in the early 2000s, and the numbers didn’t improve from 2004 to 2013.
The effects of the lack of funding are being felt in states and communities across the country.
Oregon Suffering from Lack of Funding
In Wyden’s home state of Oregon, nearly 90 percent of individuals who require opioid use disorder treatment aren’t getting it, according to the Senate report.
In 2014, 25.5 percent of all substance abuse treatment admissions in Oregon were for heroin or other opioids. Heroin accounted for 5,149 admissions, and prescription opioids accounted for 1,722, according to data from the Substance Abuse and Mental Health Services Administration.
Recent estimates indicate that about 120,000 Oregonians had an opioid use disorder between 2010 and 2014. A total of 26,909 people received treatment for any type of substance use disorder in the state that year.
Wyden’s report claimed that funding for CARA would provide $11 million to Oregon to fund new treatment centers, expand access to naloxone and train addiction specialists.
Medical Disclaimer: DrugRehab.com aims to improve the quality of life for people struggling with a substance use or mental health disorder with fact-based content about the nature of behavioral health conditions, treatment options and their related outcomes. We publish material that is researched, cited, edited and reviewed by licensed medical professionals. The information we provide is not intended to be a substitute for professional medical advice, diagnosis or treatment. It should not be used in place of the advice of your physician or other qualified healthcare provider.
Jones, C.M. (2015, August). National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26066931
Rosenblatt, R.A. et al. (2015, January-February). Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25583888
Saloner, B. & Karthikeyan, S. (2015). Changes in Substance Abuse Treatment Use Among Individuals With Opioid Use Disorders in the United States, 2004–2013. Retrieved from https://www.researchgate.net/publication/283663917_Changes_in_Substance_Abuse_Treatment_Use_Among_Individuals_With_Opioid_Use_Disorders_in_the_United_States_2004-2013
Substance Abuse and Mental Health Services Administration. (2016, July 5). Substance Abuse Treatment Admissions by Primary Substance of Abuse, According to Sex, Age Group, Race and Ethnicity. Retrieved from http://wwwdasis.samhsa.gov/webt/quicklink/OR14.htm
Calls will be answered by a qualified admissions representative with Advanced Recovery Systems (ARS), the owners of DrugRehab.com. We look forward to helping you!
Phone calls to treatment center listings not associated with ARS will go directly to those centers. DrugRehab.com and ARS are not responsible for those calls.
